TROX Investors Have Opportunity to Join Tronox Holdings plc Fraud Investigation with the Schall Law Firm
The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. Tronox reported its Q2 2025 financial results on July 30, 2025. The Company reported a 10.9% year-over-year decline in revenues, missing consensus estimates. The Company claimed that "delays in Brazil's anti-dumping investigation impacted our sales in the region." Based on this news, shares of Tronox fell by more than 37.9% on the next day.
If you are a shareholder who suffered a loss, click here to participate.
We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at bschall@schallfirm.com.
The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
2 hours ago
- Yahoo
Why Venture Global Rallied Today
Key Points Venture Global beat analyst expectations for revenue and EBITDA. The company also announced an important arbitration win in a suit brought by one of its customers. With the stock down nearly 50% from its January IPO, it may be worth a look in an otherwise expensive market. 10 stocks we like better than Venture Global › Shares of Venture Global (NYSE: VG) rallied 9.8% on Wednesday as of 1:55 p.m. ET. The liquefied natural gas export company, which is building several export terminals on the U.S. Gulf Coast, reported its second-quarter earnings last night. Results were solid and above expectations. But on top of that, the company also announced it had won an important arbitration case brought by a large customer, removing a risk that was potentially overhanging the stock. Venture delivers in Q2, and in court In the second quarter, Venture Global saw revenue of $3.1 billion, up 180% year over year, along with adjusted EBITDA (earnings before interest, taxes, depreciation, and amortization) of $1.39 billion, up 217%. Both figures came in ahead of analyst expectations. Management announced the company was ramping production of its Plaquemines terminal quicker than expected, and now expects total cargoes for the year to be at the high end of the previously given 367-389 range, which encompasses both Plaquemines as well as the first Calcasieu Pass project, which entered official commercial operations in April. However, management kept its full-year EBITDA targets unchanged. Venture Global also announced it won its arbitration case against one of its customers, Shell (NYSE: SHEL). Shell brought a case two years ago, after Venture Global opted to sell cargos on the spot market from Calcasieu Pass when LNG prices were much higher following the Russian invasion of Ukraine, rather than to Shell and other customers with which Venture had signed a long-term supply agreements at lower prices. It appears Venture's argument, that it had only sold those cargoes during the pre-commercialization phase and was thus not obligated to sell those cargoes until official commercialization, won over arbitrators. Thus, the potential overhang of financial penalties was removed, it seems. Venture Global is still half its IPO price While the near-tripling of revenues was good to see, investors can look forward to more growth in the years ahead. In late July, the company announced it had made the final decision to begin phase 1 of the second Calcasieu Pass (CP2) project, following the company securing over $15 billion in financing, all while having its credit upgraded by S&P Global. This growth will be very capital-intensive. However, with natural gas seemingly in high demand from foreign customers, both for security reasons and to power AI data centers, Venture Global should eventually be a very high-cash-flowing business. Even after today's rally, the stock is well below its January IPO price of $25. So, enterprising investors may want to dig into this story in the second half. Should you buy stock in Venture Global right now? Before you buy stock in Venture Global, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Venture Global wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $653,427!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,119,863!* Now, it's worth noting Stock Advisor's total average return is 1,060% — a market-crushing outperformance compared to 182% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of August 13, 2025 Billy Duberstein and/or his clients have no position in any of the stocks mentioned. The Motley Fool has positions in and recommends S&P Global. The Motley Fool has a disclosure policy. Why Venture Global Rallied Today was originally published by The Motley Fool
Yahoo
2 hours ago
- Yahoo
Jim Cramer In AECOM: 'I've Been Waiting for an Opportunity'
AECOM (NYSE:ACM) is one of the stocks Jim Cramer commented on. Cramer commented that he wished that the company stock 'had just cooled off for a second,' as he said: 'But the downgrade also temporarily stopped the legendary rally in the big three of engineering construction, write these down: AECOM, Jacobs Solutions, and Quanta Services. Now, I've been waiting for an opportunity. I wish these stocks had just cooled off for a second so I can tell investing club members to buy them. Stock market data showing an upward trajectory. Photo by Burak The Weekender on Pexels AECOM (NYSE:ACM) provides infrastructure consulting services, including advisory, design, engineering, construction management, and development for public and private clients. Moreover, the company invests in and develops real estate projects, serving sectors such as transportation, water, facilities, environmental, and energy. While we acknowledge the potential of ACM as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
2 hours ago
- Yahoo
Why UnitedHealth Stock Was Climbing on Wednesday
Key Points The insurer maintained its dividend policy. This was obviously a relief to worried investors. 10 stocks we like better than UnitedHealth Group › UnitedHealth (NYSE: UNH) stock was proving to be beneficial for investors' financial health on Hump Day. They were trading the big health insurance company's stock up by nearly 4% in late-session action, in no small part because of a fresh dividend declaration. That performance marked it as an outlier, as the S&P 500 index had only ticked up by 0.2% at that stage. Quarterly payout incoming Before market open, UnitedHealth's board of directors authorized the payment of a quarterly dividend of $2.21 per each of the company's common shares. This is to be dispensed on Sept. 23 to investors of record as of Sept. 15. Despite some challenges to its business recently, UnitedHealth has held steadfastly to its dividend policy. It switched from an annual to a quarterly disbursement in 2010, and has raised it on a regular basis since then. Over that stretch of time, it has risen strongly from $0.03 to the present level. Although Wednesday's dividend declaration was in character for UnitedHealth, the investor reaction might have been something of a relief rally. Earlier this year the company absorbed a big group of Medicare Advantage patients and to its surprise, those folks made more visits to doctors and other healthcare professionals than anticipated. This impacted fundamentals, and some investors were surely worried the dividend would be suspended. The high profile of a high yield Although it's unwise to buy a stock purely to clock the dividend, UnitedHealth's payout is notable for being generous. Unlike other dividend-paying healthcare stocks, this one has quite a high yield -- nearly 3.3%, against the 1.2% average of all S&P 500 index component stocks. It's little wonder investors were happy the company is maintaining its payout. Should you buy stock in UnitedHealth Group right now? Before you buy stock in UnitedHealth Group, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and UnitedHealth Group wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $653,427!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,119,863!* Now, it's worth noting Stock Advisor's total average return is 1,060% — a market-crushing outperformance compared to 182% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of August 13, 2025 Eric Volkman has no position in any of the stocks mentioned. The Motley Fool recommends UnitedHealth Group. The Motley Fool has a disclosure policy. Why UnitedHealth Stock Was Climbing on Wednesday was originally published by The Motley Fool
